Abstract
1. Convulsions were induced reproducibly by intracerebroventricular injection of N-methyl-D-aspartic acid (NMDA) to conscious mice. 2. Competitive (carboxypiperazine-propylphosphonic acid, CPP; 2-amino-7-phosphonoheptanoic acid, AP7) and non-competitive (MK801; phencyclidine, PCP; thienylcyclohexylpiperidine, TCP; dextrorphan; dextromethorphan) NMDA antagonists prevented NMDA-induced convulsions. 3. Benzodiazepine receptor agonists and partial agonists (triazolam, diazepam, clonazepam, Ro 16-6028), classical anticonvulsants (diphenylhydantoin, phenobarbitone, sodium valproate) and meprobamate were also found to prevent NMDA-induced convulsions. 4. Flumazenil (a benzodiazepine receptor antagonist) and the GABA agonists THIP and muscimol (up to subtoxic doses) were without effect. 5. Flumazenil reversed the anticonvulsant action of diazepam, but not that of MK801. 6. Results obtained in this model differ somewhat from those described in a seizure model with systemic administration of NMDA. An explanation for this discrepancy is offered. 7. This model is a simple test for assessing the in vivo activity of NMDA antagonists and also expands the battery of chemically-induced seizure models for characterizing anticonvulsants not acting at NMDA receptors.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Choi D. W. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1988 Oct;1(8):623–634. doi: 10.1016/0896-6273(88)90162-6. [DOI] [PubMed] [Google Scholar]
- Clark W. G., Vivonia C. A., Baxter C. F. Accurate freehand injection into the lateral brain ventricle of the conscious mouse. J Appl Physiol. 1968 Sep;25(3):319–321. doi: 10.1152/jappl.1968.25.3.319. [DOI] [PubMed] [Google Scholar]
- Czuczwar S. J., Frey H. H., Löscher W. Antagonism of N-methyl-D,L-aspartic acid-induced convulsions by antiepileptic drugs and other agents. Eur J Pharmacol. 1985 Feb 5;108(3):273–280. doi: 10.1016/0014-2999(85)90449-2. [DOI] [PubMed] [Google Scholar]
- Czuczwar S. J., Meldrum B. Protection against chemically induced seizures by 2-amino-7-phosphonoheptanoic acid. Eur J Pharmacol. 1982 Sep 24;83(3-4):335–338. doi: 10.1016/0014-2999(82)90273-4. [DOI] [PubMed] [Google Scholar]
- Ferkany J. W., Borosky S. A., Clissold D. B., Pontecorvo M. J. Dextromethorphan inhibits NMDA-induced convulsions. Eur J Pharmacol. 1988 Jun 22;151(1):151–154. doi: 10.1016/0014-2999(88)90707-8. [DOI] [PubMed] [Google Scholar]
- Hunkeler W., Möhler H., Pieri L., Polc P., Bonetti E. P., Cumin R., Schaffner R., Haefely W. Selective antagonists of benzodiazepines. Nature. 1981 Apr 9;290(5806):514–516. doi: 10.1038/290514a0. [DOI] [PubMed] [Google Scholar]
- Leander J. D., Lawson R. R., Ornstein P. L., Zimmerman D. M. N-methyl-D-aspartic acid-induced lethality in mice: selective antagonism by phencyclidine-like drugs. Brain Res. 1988 May 10;448(1):115–120. doi: 10.1016/0006-8993(88)91107-9. [DOI] [PubMed] [Google Scholar]
- Martin J. R., Pieri L., Bonetti E. P., Schaffner R., Burkard W. P., Cumin R., Haefely W. E. Ro 16-6028: a novel anxiolytic acting as a partial agonist at the benzodiazepine receptor. Pharmacopsychiatry. 1988 Nov;21(6):360–362. doi: 10.1055/s-2007-1021947. [DOI] [PubMed] [Google Scholar]
- Meldrum B. Possible therapeutic applications of antagonists of excitatory amino acid neurotransmitters. Clin Sci (Lond) 1985 Feb;68(2):113–122. doi: 10.1042/cs0680113. [DOI] [PubMed] [Google Scholar]
- VonVoigtlander P. F., Hall E. D., Ochoa M. C., Lewis R. A., Triezenberg H. J. U-54494A: a unique anticonvulsant related to kappa opioid agonists. J Pharmacol Exp Ther. 1987 Nov;243(2):542–547. [PubMed] [Google Scholar]